Sertraline
- Generic Name
- Sertraline
- Brand Names
- Zoloft
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17Cl2N
- CAS Number
- 79617-96-2
- Unique Ingredient Identifier
- QUC7NX6WMB
- Background
Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as Citalopram and Fluoxetine. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.
...
- Indication
Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD). Common off-label uses for sertraline include the prevention of post stroke depression, generalized anxiety di...
- Associated Conditions
- Binge Eating Disorder (BED), Bulimia Nervosa, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Post Traumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), Social Anxiety Disorder (SAD)
- Associated Therapies
- -
Integral Assessment in Unipolar Depression
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2015-12-11
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 100
- Registration Number
- NCT02268487
- Locations
- 🇧🇷
Insitute of Psychiatry of the University of São Paulo, São Paulo, Brazil
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- HolsboerMaschmeyer NeuroChemie GmbH
- Target Recruit Count
- 80
- Registration Number
- NCT02237937
- Locations
- 🇩🇪
Max Planck Institute of Psychiatry, Munich, Bavaria, Germany
Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 2
- Registration Number
- NCT02235064
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults
- First Posted Date
- 2014-08-28
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 25
- Registration Number
- NCT02228005
- Locations
- 🇨🇦
Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
- Conditions
- Interventions
- First Posted Date
- 2014-07-14
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 14
- Registration Number
- NCT02189213
- Locations
- 🇺🇸
NYSPI, New York, New York, United States
Effects and Consequences for Mother and Child From Treatment for Depression
- First Posted Date
- 2014-07-09
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Katarina Wide
- Target Recruit Count
- 17
- Registration Number
- NCT02185547
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Sweden
Antidepressants and Bone Mineral Density
- Conditions
- Interventions
- First Posted Date
- 2014-07-01
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- Guiyang Medical University
- Target Recruit Count
- 203
- Registration Number
- NCT02179268
Study of Drug Combination on Pharmacokinetics in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 41
- Registration Number
- NCT02175602
A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression
- Conditions
- Interventions
- First Posted Date
- 2014-04-24
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 45
- Registration Number
- NCT02122393
- Locations
- 🇦🇺
Austin Health, Melbourne, Victoria, Australia
Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Shanghai Mental Health Center
- Target Recruit Count
- 78
- Registration Number
- NCT02022709
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.